MedTrace Logo

Effect of SVV Guided Fluid Therapy on Blood Loss and Postoperative Outcomes

NCT02373735 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 64

Last updated 2015-12-30

No results posted yet for this study

Summary

The purpose of this study is to investigate the effect of stroke volume variation (SVV) guided fluid therapy on the blood loss and postoperative outcomes in radical cystectomy.

Conditions

Interventions

OTHER

crystalloid

Group A (SVV \<10%): infuse crystalloid 6-10 ml/kg/hr during surgery. Group B (SVV 10-20%): infuse crystalloid 2-4 ml/kg/hr until cystectomy, 6-10 ml/kg/hr after cystectomy

OTHER

colloid

Group A (SVV \<10%): infuse colloid 200 ml if SVV is ≥ 10%. Group B (SVV 10-20%): infuse colloid 200 ml if SVV is \> 20%

OTHER

mannitol

Group B (SVV 10-20%): infuse mannitol 0.5 g/kg if SVV is \< 10%

OTHER

lasix

Group B (SVV 10-20%): infuse lasix 5 mg if SVV is \< 10%

Sponsors & Collaborators

  • Asan Medical Center

    lead OTHER

Principal Investigators

  • Young-Kug Kim, M.D., Ph.D · Asan Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-03-31
Primary Completion
2015-11-30
Completion
2015-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02373735 on ClinicalTrials.gov